MR imaging findings in hepatic encephalopathy.

PubWeight™: 2.14‹?› | Rank: Top 2%

🔗 View Article (PMID 18583413)

Published in AJNR Am J Neuroradiol on June 26, 2008

Authors

A Rovira1, J Alonso, J Córdoba

Author Affiliations

1: Magnetic Resonance Unit, Department of Radiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. alex.rovira@idi-cat.org

Articles citing this

Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol (2015) 1.58

Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol (2010) 1.58

The etiology of cirrhosis is a strong determinant of brain reserve: A multimodal magnetic resonance imaging study. Liver Transpl (2015) 1.48

Encephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapy. Crit Care Med (2011) 1.43

Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics (2010) 1.19

Intrahepatic portosystemic venous shunt: successful embolization using the Amplatzer Vascular Plug II. Korean J Radiol (2012) 1.14

Classic neuroimaging findings of nonketotic hyperglycemia on computed tomography and magnetic resonance imaging with absence of typical movement disorder symptoms (hemichorea-hemiballism). J Radiol Case Rep (2013) 1.10

Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status. Neuroradiology (2016) 1.07

Ammonia toxicity to the brain. J Inherit Metab Dis (2012) 1.04

Alcohol-induced changes in the brain as assessed by MRI and CT. Eur Radiol (2009) 0.98

Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol (2011) 0.94

The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study. PLoS One (2012) 0.93

Intracranial lesions with high signal intensity on T1-weighted MR images - review of pathologies. Pol J Radiol (2013) 0.93

Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report. Korean J Radiol (2013) 0.91

The role of glutamine synthetase and glutamate dehydrogenase in cerebral ammonia homeostasis. Neurochem Res (2012) 0.91

Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed (2013) 0.90

13N as a tracer for studying glutamate metabolism. Neurochem Int (2010) 0.87

Toxic and metabolic encephalopathies: iconographic essay. Radiol Bras (2015) 0.85

The C57BL/6J mouse exhibits sporadic congenital portosystemic shunts. PLoS One (2013) 0.84

Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics. Eur Radiol (2013) 0.84

Congenital absence of the portal vein in a patient with multiple vascular anomalies. Surg Radiol Anat (2012) 0.80

Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years. Eur Radiol (2016) 0.80

Aberrant resting-state corticostriatal functional connectivity in cirrhotic patients with hyperintense globus pallidus on T1-weighted MR imaging. PLoS One (2012) 0.78

Lesions in basal ganglia in a patient with involuntary movements as a first sign of diabetes - case report and review of the literature. Pol J Radiol (2010) 0.78

Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain. Neuroradiology (2014) 0.77

Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy. Magn Reson Insights (2008) 0.77

MR differential diagnosis of acute deep grey matter pathology in paediatric patients. Pediatr Radiol (2012) 0.77

Rifaximin in the treatment of hepatic encephalopathy. Hepat Med (2011) 0.76

Metronidazole-induced encephalopathy in a patient with end-stage liver disease. Case Reports Hepatol (2012) 0.76

Current Stance of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Hepatic Encephalopathy. Maedica (Buchar) (2015) 0.75

MR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization. Neuroradiol J (2014) 0.75

A rare characteristic neuroimaging pattern in hyperammonaemia. Ulster Med J (2017) 0.75

Concomitants of alcoholism: differential effects of thiamine deficiency, liver damage, and food deprivation on the rat brain in vivo. Psychopharmacology (Berl) (2016) 0.75

Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol (2016) 0.75

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A 1H-Magnetic Resonance Spectroscopy Study. PLoS One (2016) 0.75

A urinary cause of coma. J Neurol (2010) 0.75

Diabetes Mellitus is Associated with More Severe Brain Spontaneous Activity Impairment and Gray Matter Loss in Patients with Cirrhosis. Sci Rep (2017) 0.75

Ingestion of gasoline in a suicide attempt: an uncommon cause of bilateral basal ganglia T1 hyperintensities. Neurol Sci (2010) 0.75

Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study. Dig Dis Sci (2016) 0.75

Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models. Alcohol Res (2017) 0.75

Magnetic resonance imaging patterns of treatment-related toxicity in the pediatric brain: an update and review of the literature. Pediatr Radiol (2016) 0.75

Refractory hepatic encephalopathy in a patient with hypothyroidism: Another element in ammonia metabolism. World J Gastroenterol (2017) 0.75

Parkinsonism and high-intensity midbrain lesions on T2-weighted imaging in hepatic encephalopathy: a case report. Neurol Sci (2017) 0.75

Unilateral basal-ganglia involvement likely due to valproate-induced hyperammonemic encephalopathy. Neurol Sci (2011) 0.75

Articles by these authors

The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol (2011) 9.40

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 7.56

Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry (2007) 4.69

Evaluating quality-of-life and health status instruments: development of scientific review criteria. Clin Ther (1997) 2.92

The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res (2008) 2.81

Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 2.77

Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 2.67

International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl (2003) 2.63

HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol (2000) 2.60

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med (1997) 2.45

The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42

Hepatic Encephalopathy. Am J Gastroenterol (2001) 2.37

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 2.30

Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments. BMC Med Res Methodol (2006) 2.23

Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22

Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys. Psychol Med (2008) 2.15

Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord (2007) 2.12

Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05

Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 2.02

Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res (1998) 2.00

Provision of feedback on perceived health status to health care professionals: a systematic review of its impact. Med Care (2000) 1.92

Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis (1993) 1.89

Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86

Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85

Obesity and mental disorders in the general population: results from the world mental health surveys. Int J Obes (Lond) (2007) 1.82

Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord (2006) 1.81

Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology (1999) 1.76

Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J (1996) 1.72

Cross-cultural adaptation of health measures. European Group for Health Management and Quality of Life Assessment. Health Policy (1991) 1.68

Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 1.65

Variation in indications for cataract surgery in the United States, Denmark, Canada, and Spain: results from the International Cataract Surgery Outcomes Study. Br J Ophthalmol (1998) 1.64

Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med (1995) 1.63

Relationship of health behaviours to five-year mortality in an elderly cohort. Age Ageing (1995) 1.60

The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occup Environ Med (2008) 1.59

Burden of illness of Crohn's disease in Spain. Dig Liver Dis (2003) 1.57

Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci (1998) 1.54

Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology (1996) 1.52

31P-MRS of quadriceps reveals quantitative differences between sprinters and long-distance runners. Med Sci Sports Exerc (1993) 1.51

[Osteoarticular disorders in the elderly: an approach to their population impact]. Med Clin (Barc) (1996) 1.50

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J (2003) 1.49

Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur Respir J (2002) 1.48

[Proposal for a social class measure. Working Group of the Spanish Society of Epidemiology and the Spanish Society of Family and Community Medicine]. Aten Primaria (2000) 1.48

12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl (2004) 1.44

[Inadequate hospital admissions and inactive days of hospital stay in patients with chronic obstructive pulmonary disease and lung neoplasms]. Med Clin (Barc) (1993) 1.44

[Assessment of quality of life related to health 2 years after coronary surgery]. Med Clin (Barc) (1997) 1.43

Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med (2001) 1.43

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

[Attitudes to the seeking of psychiatric help from mental health care professionals and actually seeking help: differences in Europe]. Tijdschr Psychiatr (2010) 1.40

The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res (1999) 1.40

Patients' acceptance of waiting for cataract surgery: what makes a wait too long? Soc Sci Med (1997) 1.39

[Place of death of elderly persons in Catalonia]. Rev Clin Esp (2006) 1.39

Visual outcomes of cataract surgery in the United States, Canada, Denmark, and Spain. Report From the International Cataract Surgery Outcomes Study. Arch Ophthalmol (1998) 1.38

Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig (2000) 1.37

Treatment adequacy for anxiety and depressive disorders in six European countries. Br J Psychiatry (2007) 1.34

Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1999) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

[The quality-of-life questionnaire with asthma patients: the Spanish version of the Asthma Quality of Life Questionnaire]. Arch Bronconeumol (1995) 1.28

Evidence that an endothelial cytosolic protein binds to the 3'-untranslated region of endothelial nitric oxide synthase mRNA. J Vasc Res (1999) 1.27

Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy (2008) 1.26

Are attitudes towards mental health help-seeking associated with service use? Results from the European Study of Epidemiology of Mental Disorders. Soc Psychiatry Psychiatr Epidemiol (2009) 1.25

Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology (2002) 1.25

DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells. Oncogene (2008) 1.23

De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Liver Transpl (2001) 1.22

Mental disorders among persons with arthritis: results from the World Mental Health Surveys. Psychol Med (2008) 1.22

Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther (2007) 1.21

Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries. Acta Psychiatr Scand (2006) 1.20

Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): a four-year follow-up. J Am Coll Cardiol (1999) 1.16

Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed (1998) 1.14

Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia. Am J Respir Crit Care Med (1999) 1.13

Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene (2007) 1.13

Psychometric properties of the World Health Organization Disability Assessment Schedule used in the European Study of the Epidemiology of Mental Disorders. Int J Methods Psychiatr Res (2008) 1.12

A multinational study of mental disorders, marriage, and divorce. Acta Psychiatr Scand (2011) 1.12

Comparison of the results of first and second cataract eye surgery. Ophthalmology (1999) 1.12

Parental psychopathology and the risk of suicidal behavior in their offspring: results from the World Mental Health surveys. Mol Psychiatry (2010) 1.12

Willingness to pay to shorten waiting time for cataract surgery. Health Aff (Millwood) (1997) 1.10

Metastatic follicular thyroid carcinoma to the kidney: a case report. Clin Nucl Med (1999) 1.10

Methadone and quality of life. Lancet (1999) 1.10

Distal femoral fracture fixation utilizing the Less Invasive Stabilization System (L.I.S.S.): the technique and early results. Injury (2001) 1.09

Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol (1990) 1.08

Age patterns in the prevalence of DSM-IV depressive/anxiety disorders with and without physical co-morbidity. Psychol Med (2008) 1.07

Are results of the SF-36 health survey and the Nottingham Health Profile similar? A comparison in COPD patients. Quality of Life in COPD Study Group. J Clin Epidemiol (1997) 1.07

Recurrent meningitis from a multiply resistant Streptococcus pneumoniae strain treated with erythromycin. Pediatr Infect Dis J (1991) 1.05

Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatr Scand (2005) 1.05

Structure of proline iminopeptidase from Xanthomonas campestris pv. citri: a prototype for the prolyl oligopeptidase family. EMBO J (1998) 1.05

Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction (1997) 1.04

Toll receptor 4 Asp299Gly polymorphism and its association with preterm birth and premature rupture of membranes in a South American population. Mol Hum Reprod (2008) 1.03

Is patient-centredness in European hospitals related to existing quality improvement strategies? Analysis of a cross-sectional survey (MARQuIS study). Qual Saf Health Care (2009) 1.03

Mercury in edible mushrooms and underlying soil: bioconcentration factors and toxicological risk. Sci Total Environ (2009) 1.02

Association between educational level and health related quality of life in Spanish adults. J Epidemiol Community Health (1999) 1.02

A continuum between scapulothoracic dissociation and traumatic forequarter amputation: a review of the literature. Am Surg (2001) 1.02

Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol (1991) 1.02

Health-related quality of life in young cocaine users and associated factors. Qual Life Res (2008) 1.02

Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int Suppl (1993) 1.01

The European Schizophrenia Outpatient Health Outcomes Study: baseline findings across country and treatment. Acta Psychiatr Scand Suppl (2003) 1.01

Mediators of the association between depression and role functioning. Acta Psychiatr Scand (2008) 1.00

Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation (1992) 1.00